ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 248 filers reported holding ICU MED INC in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $308,750 | -94.2% | 2,600 | -94.7% | 0.00% | -93.5% |
| Q1 2024 | $5,313,199 | +92.3% | 49,508 | +78.7% | 0.03% | +72.2% |
| Q4 2023 | $2,762,798 | +738.6% | 27,700 | +1398.1% | 0.02% | +800.0% |
| Q2 2023 | $329,473 | +49820.2% | 1,849 | +46125.0% | 0.00% | – |
| Q1 2023 | $660 | -99.9% | 4 | -99.9% | 0.00% | -100.0% |
| Q4 2022 | $1,011,337 | +19.8% | 6,422 | +25.1% | 0.01% | +20.0% |
| Q2 2022 | $844,000 | -85.4% | 5,133 | -80.2% | 0.01% | -89.8% |
| Q1 2022 | $5,775,000 | +79.1% | 25,940 | +91.0% | 0.05% | +58.1% |
| Q4 2021 | $3,224,000 | -51.4% | 13,583 | -52.2% | 0.03% | -63.1% |
| Q3 2021 | $6,630,000 | +1316.7% | 28,407 | +1148.7% | 0.08% | +1580.0% |
| Q2 2021 | $468,000 | +181.9% | 2,275 | +182.3% | 0.01% | +150.0% |
| Q1 2021 | $166,000 | -84.3% | 806 | -83.7% | 0.00% | -86.7% |
| Q4 2020 | $1,059,000 | -20.3% | 4,935 | -32.1% | 0.02% | -25.0% |
| Q3 2020 | $1,329,000 | -46.3% | 7,272 | -45.8% | 0.02% | -53.5% |
| Q2 2020 | $2,474,000 | +2776.7% | 13,421 | +3057.9% | 0.04% | +2050.0% |
| Q1 2020 | $86,000 | -91.8% | 425 | -92.4% | 0.00% | -89.5% |
| Q4 2019 | $1,048,000 | -74.8% | 5,602 | -78.5% | 0.02% | -77.1% |
| Q3 2019 | $4,159,000 | +3003.7% | 26,060 | +5397.9% | 0.08% | +1085.7% |
| Q3 2018 | $134,000 | -97.7% | 474 | -97.6% | 0.01% | -97.6% |
| Q2 2018 | $5,849,000 | +3906.2% | 19,919 | +2846.6% | 0.29% | +3575.0% |
| Q4 2017 | $146,000 | -74.5% | 676 | -78.0% | 0.01% | -75.0% |
| Q3 2017 | $572,000 | +152.0% | 3,077 | +70.9% | 0.03% | +113.3% |
| Q3 2016 | $227,000 | -35.7% | 1,800 | -42.5% | 0.02% | -28.6% |
| Q4 2015 | $353,000 | +29.3% | 3,133 | +9.9% | 0.02% | +61.5% |
| Q2 2015 | $273,000 | -73.2% | 2,852 | -77.0% | 0.01% | -76.4% |
| Q4 2014 | $1,017,000 | +291.2% | 12,420 | +206.4% | 0.06% | +243.8% |
| Q3 2014 | $260,000 | – | 4,053 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
| CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
| PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
| Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
| GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
| Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
| Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
| PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
| DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
| GAM Holding AG | 90,452 | $20,769,000 | 1.05% |